2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | 0.00 | NA | NA | NA | |
dei: Entity Common Stock Shares Outstanding | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Weighted Average Number Of Diluted Shares Outstanding | 722.72 | 735.47 | 781.63 | NA | 844.46 | 770.23 | 759.27 | NA | 713.32 | 699.89 | 695.88 | NA | 686.59 | 650.23 | 649.86 | NA | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | 722.72 | 735.47 | 735.82 | NA | 800.59 | 770.23 | 759.27 | NA | 713.32 | 699.89 | 695.88 | NA | 686.59 | 650.23 | 649.86 | NA | NA | NA | NA | |
Earnings Per Share Basic | 0.23 | -0.31 | 0.13 | -0.24 | 6.37 | -0.40 | -0.38 | -0.03 | -0.49 | -0.42 | -0.48 | -0.39 | -0.41 | -0.32 | -0.13 | NA | NA | NA | NA | |
Earnings Per Share Diluted | 0.23 | -0.31 | 0.12 | -0.23 | 6.03 | -0.40 | -0.38 | -0.03 | -0.49 | -0.42 | -0.48 | -0.39 | -0.41 | -0.32 | -0.13 | NA | NA | NA | NA | |
Income Loss From Continuing Operations Per Basic Share | -0.00 | -0.00 | NA | -0.00 | 0.00 | -0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Income Loss From Continuing Operations Per Diluted Share | -0.00 | -0.00 | NA | -0.00 | 0.00 | -0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 9.02 | 4.47 | 55.13 | 28.93 | 37.14 | 37.10 | 21.62 | 27.38 | 17.05 | 12.53 | 4.32 | 9.22 | 24.34 | 13.99 | 7.74 | 15.15 | 5.75 | 1.32 | 1.58 | |
Revenues | 9.02 | 4.47 | 55.13 | 28.93 | 37.14 | 37.10 | 21.62 | 27.38 | 17.05 | 12.53 | 4.32 | 9.22 | 24.34 | 13.99 | 7.74 | 15.15 | 5.75 | 1.32 | 1.58 | |
Gain Loss On Investments | -21.31 | 48.38 | 15.23 | 15.91 | -10.47 | -45.85 | -7.56 | 32.46 | 25.95 | -54.68 | -24.55 | -72.91 | -38.04 | 32.27 | -8.62 | -11.68 | -18.23 | 84.30 | 41.15 | |
Operating Expenses | 283.40 | 346.19 | 285.70 | 294.93 | 324.67 | 313.56 | 298.04 | 261.54 | 395.13 | 293.30 | 286.63 | 276.03 | 270.36 | 698.42 | 162.12 | 555.98 | 264.82 | 157.86 | 116.03 | |
Research And Development Expense | 141.59 | 143.07 | 133.21 | 120.90 | 123.72 | 131.98 | 125.13 | 131.86 | 125.53 | 132.00 | 135.83 | -3.30 | 153.45 | 254.26 | 78.63 | -121.78 | 202.26 | 97.41 | 58.73 | |
General And Administrative Expense | 141.54 | 202.88 | NA | NA | 128.17 | 88.58 | NA | NA | NA | NA | 149.07 | 138.97 | 115.53 | 437.78 | 82.75 | 81.15 | 61.88 | 59.74 | 57.12 | |
Operating Income Loss | -274.38 | -341.71 | -120.19 | -266.00 | 5060.88 | -276.45 | -276.41 | -234.17 | -378.08 | -280.77 | -282.31 | -266.80 | -246.02 | -684.43 | -154.39 | -540.83 | -259.07 | -156.54 | -114.45 | |
Income Loss From Continuing Operations | -157.64 | -187.10 | NA | -377.76 | 5154.47 | -218.23 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Income Tax Expense Benefit | -25.57 | 12.46 | 12.65 | -8.96 | 25.67 | 3.76 | 1.75 | -3.79 | 2.82 | 2.17 | 4.00 | -0.16 | 0.04 | 0.40 | 0.09 | -0.02 | -0.22 | 0.71 | 1.22 | |
Profit Loss | 118.08 | -279.92 | 57.49 | -182.50 | 5072.66 | -331.12 | -327.85 | -60.86 | -384.90 | -315.92 | -353.78 | -291.31 | -306.08 | -225.64 | -101.08 | -563.16 | -275.60 | -53.50 | -7.98 | |
Other Comprehensive Income Loss Net Of Tax | 26.11 | 0.21 | -13.83 | 24.68 | -25.07 | 3.60 | -4.15 | -2.04 | -8.97 | 3.75 | 5.77 | 0.02 | -2.39 | 2.54 | -2.44 | 11.22 | -5.54 | -1.03 | -0.82 | |
Net Income Loss | 169.38 | -230.18 | 95.30 | -151.12 | 5096.18 | -304.33 | -291.82 | -33.62 | -352.01 | -291.59 | -331.81 | -270.06 | -284.54 | -208.48 | -82.18 | -509.56 | -261.03 | -35.40 | -3.24 | |
Comprehensive Income Net Of Tax | 195.47 | -230.27 | 81.43 | -127.41 | 5071.47 | -300.79 | -295.81 | -35.51 | -361.83 | -287.52 | -325.84 | -269.94 | -286.89 | -205.99 | -84.83 | -498.04 | -266.83 | -36.47 | -4.10 |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 5792.35 | 6206.03 | 6496.45 | 7222.48 | 7312.68 | 2065.54 | 2136.65 | 2389.60 | 2202.96 | 2215.53 | 2600.40 | 2585.13 | 2799.38 | 3102.91 | 2454.70 | 2589.69 | NA | NA | NA | |
Liabilities | 256.38 | 625.99 | 601.16 | 773.95 | 728.10 | 739.91 | 802.51 | 782.02 | 775.82 | 701.38 | 822.52 | 523.70 | 529.62 | 652.01 | 474.87 | 527.69 | NA | NA | NA | |
Liabilities And Stockholders Equity | 5792.35 | 6206.03 | 6496.45 | 7222.48 | 7312.68 | 2065.54 | 2136.65 | 2389.60 | 2202.96 | 2215.53 | 2600.40 | 2585.13 | 2799.38 | 3102.91 | 2454.70 | 2589.69 | NA | NA | NA | |
Stockholders Equity | 5189.47 | 5152.95 | 5435.31 | 5968.58 | 6089.76 | 948.53 | 910.73 | 1157.77 | 955.52 | 1160.60 | 1384.11 | 1656.94 | 1865.72 | 2038.02 | 1723.12 | 1797.79 | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 5363.97 | 5801.12 | 6001.50 | 6731.83 | 6806.73 | 1551.63 | 1561.16 | 1798.59 | 1646.23 | 1714.86 | 2039.44 | 2146.52 | 2287.53 | 2555.75 | 2057.61 | 2186.99 | NA | NA | NA | |
Cash | 99.08 | 123.48 | NA | 182.66 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Cash And Cash Equivalents At Carrying Value | 1990.68 | 1958.63 | 5678.51 | 6535.71 | 6670.81 | 1408.23 | 1434.09 | 1676.81 | 1527.44 | 1599.02 | 1942.21 | 2060.40 | 2214.28 | 2497.33 | 1996.73 | 2055.04 | NA | NA | NA | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2001.67 | 1969.91 | 5693.30 | 6550.45 | 6685.46 | 1423.19 | 1449.65 | 1692.12 | 1541.04 | 1612.65 | 1956.47 | 2074.03 | 2226.14 | 2509.12 | 2008.38 | 2141.68 | 2153.12 | 2389.62 | 2313.57 | |
Marketable Securities Current | 3155.82 | 3428.02 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Receivables Net Current | 0.68 | 1.92 | 79.79 | 53.55 | 41.08 | 52.12 | 37.06 | 30.38 | 27.97 | 25.04 | NA | 3.88 | NA | NA | NA | NA | NA | NA | NA | |
Other Assets Current | 217.46 | 94.23 | 322.99 | 196.12 | 135.92 | 143.40 | 127.06 | 121.77 | 118.80 | 111.85 | 93.27 | 82.22 | 70.33 | 55.56 | 58.16 | 54.25 | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Net | 13.56 | 13.67 | 17.84 | 19.06 | 21.86 | 24.48 | 36.27 | 39.09 | 37.30 | 39.17 | 31.69 | 25.91 | 21.61 | 16.90 | 15.55 | 14.75 | NA | NA | NA | |
Other Assets Noncurrent | 33.88 | 36.90 | 32.81 | 39.11 | 46.85 | 49.80 | 46.31 | 49.48 | 46.22 | 11.87 | 12.82 | 16.09 | 20.88 | 21.34 | 26.52 | 27.20 | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 141.48 | 556.25 | 215.04 | 266.76 | 244.90 | 265.55 | 245.00 | 272.45 | 244.25 | 230.74 | 328.92 | 184.37 | 160.71 | 303.44 | 209.16 | 218.96 | NA | NA | NA | |
Accounts Payable Current | 23.71 | 25.13 | 27.74 | 53.23 | 35.23 | 44.12 | 50.03 | 37.83 | 48.00 | 41.36 | 161.30 | 34.58 | 24.36 | 77.16 | 15.01 | 20.55 | NA | NA | NA | |
Other Accrued Liabilities Current | 11.58 | 16.32 | 26.27 | 50.75 | 20.31 | 30.70 | 25.45 | 18.10 | 17.69 | 34.06 | NA | 17.08 | NA | NA | NA | NA | NA | NA | NA | |
Taxes Payable Current | 0.58 | 5.41 | 23.44 | 10.47 | 25.22 | 1.36 | 1.24 | 0.54 | 5.64 | NA | NA | 0.71 | 0.81 | 0.64 | 0.20 | 0.21 | NA | NA | NA | |
Accrued Liabilities Current | 104.32 | 111.47 | 138.29 | 175.59 | 122.15 | 152.92 | 119.33 | 167.13 | 132.36 | 128.81 | 109.35 | 127.53 | 112.68 | 104.11 | 73.79 | 76.94 | NA | NA | NA | |
Other Liabilities Current | 3.61 | 8.92 | 27.52 | 16.05 | 31.34 | 8.60 | 19.89 | 15.08 | 14.31 | 5.05 | 4.08 | 0.71 | 12.44 | 10.66 | 8.30 | 9.16 | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Minority Interest | 346.50 | 427.09 | 459.98 | 479.95 | 494.82 | 377.10 | 423.41 | 449.82 | 471.62 | 353.55 | 371.28 | 382.00 | 381.54 | 390.39 | 234.22 | 241.73 | NA | NA | NA | |
Other Liabilities Noncurrent | 0.31 | 0.29 | 1.66 | 3.60 | 4.43 | 5.17 | 16.90 | 17.03 | 21.48 | 9.10 | 8.16 | 8.18 | 8.18 | 8.19 | 8.19 | 8.17 | NA | NA | NA | |
Operating Lease Liability Noncurrent | 90.48 | 43.19 | 45.85 | 47.27 | 47.06 | 48.63 | 51.81 | 53.48 | 54.92 | 54.09 | 60.40 | 62.47 | 62.09 | 65.22 | 65.26 | 62.38 | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 5189.47 | 5152.95 | 5435.31 | 5968.58 | 6089.76 | 948.53 | 910.73 | 1157.77 | 955.52 | 1160.60 | 1384.11 | 1656.94 | 1865.72 | 2038.02 | 1723.12 | 1797.79 | NA | NA | NA | |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5535.97 | 5580.04 | 5895.29 | 6448.53 | 6584.58 | 1325.63 | 1334.14 | 1607.59 | 1427.14 | 1514.15 | 1755.39 | 2038.94 | 2247.26 | 2428.41 | 1957.34 | 2039.51 | 2171.27 | 2414.36 | 2269.76 | |
Additional Paid In Capital | 4721.02 | 4775.41 | 4781.79 | 5396.49 | 5390.26 | 5320.50 | 4981.91 | 4933.14 | 4695.39 | 4538.64 | 4474.62 | 4421.61 | 4360.45 | 4245.86 | 3824.97 | 3814.80 | NA | NA | NA | |
Retained Earnings Accumulated Deficit | 460.40 | 395.58 | 671.47 | 576.17 | 727.29 | -4368.90 | -4064.57 | -3772.75 | -3739.14 | -3387.12 | -3095.53 | -2763.72 | -2493.66 | -2209.13 | -2000.64 | -1918.46 | NA | NA | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | 8.06 | -18.04 | -17.95 | -4.08 | -27.78 | -3.07 | -6.61 | -2.62 | -0.73 | 9.09 | 5.02 | -0.95 | -1.07 | 1.28 | -1.21 | 1.45 | NA | NA | NA | |
Minority Interest | 346.50 | 427.09 | 459.98 | 479.95 | 494.82 | 377.10 | 423.41 | 449.82 | 471.62 | 353.55 | 371.28 | 382.00 | 381.54 | 390.39 | 234.22 | 241.73 | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -207.25 | -266.81 | -192.83 | -108.46 | -210.45 | -196.43 | -249.93 | -179.09 | -222.59 | -189.63 | -252.08 | -147.47 | -268.49 | -120.60 | -141.17 | -106.07 | -236.86 | -98.05 | -111.17 | |
Net Cash Provided By Used In Investing Activities | 454.07 | -3293.59 | -0.96 | 6.93 | 5233.04 | -36.45 | 0.10 | 113.55 | -3.51 | -146.85 | -7.46 | -5.70 | -6.07 | 317.41 | -2.34 | -4.09 | -0.11 | -1.86 | -25.64 | |
Net Cash Provided By Used In Financing Activities | -272.95 | -109.07 | -660.62 | -32.62 | 236.64 | 207.87 | 7.48 | 210.33 | 154.50 | -7.34 | 141.98 | 1.07 | -8.42 | 303.93 | 10.21 | 98.71 | 0.46 | 175.96 | 181.13 |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -207.25 | -266.81 | -192.83 | -108.46 | -210.45 | -196.43 | -249.93 | -179.09 | -222.59 | -189.63 | -252.08 | -147.47 | -268.49 | -120.60 | -141.17 | -106.07 | -236.86 | -98.05 | -111.17 | |
Net Income Loss | 169.38 | -230.18 | 95.30 | -151.12 | 5096.18 | -304.33 | -291.82 | -33.62 | -352.01 | -291.59 | -331.81 | -270.06 | -284.54 | -208.48 | -82.18 | -509.56 | -261.03 | -35.40 | -3.24 | |
Profit Loss | 118.08 | -279.92 | 57.49 | -182.50 | 5072.66 | -331.12 | -327.85 | -60.86 | -384.90 | -315.92 | -353.78 | -291.31 | -306.08 | -225.64 | -101.08 | -563.16 | -275.60 | -53.50 | -7.98 | |
Depreciation Depletion And Amortization | 2.92 | 4.84 | 4.88 | 5.22 | 5.38 | 5.59 | 5.84 | 5.95 | 5.15 | 5.08 | 2.68 | 1.71 | 1.37 | NA | NA | NA | NA | NA | NA | |
Increase Decrease In Other Operating Capital Net | 6.39 | 20.51 | -12.27 | NA | -27.42 | -5.14 | -9.43 | 0.04 | -20.52 | 10.73 | 6.45 | 6.44 | 12.54 | -3.89 | -3.71 | 10.51 | 29.21 | -5.62 | 3.74 | |
Share Based Compensation | 83.68 | 71.67 | 50.19 | 46.72 | 54.33 | 49.32 | 49.26 | 25.28 | 57.73 | 61.98 | 72.79 | 77.16 | 71.22 | 397.31 | 19.27 | 39.44 | 17.32 | 13.91 | 14.28 |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | 454.07 | -3293.59 | -0.96 | 6.93 | 5233.04 | -36.45 | 0.10 | 113.55 | -3.51 | -146.85 | -7.46 | -5.70 | -6.07 | 317.41 | -2.34 | -4.09 | -0.11 | -1.86 | -25.64 | |
Payments To Acquire Property Plant And Equipment | 1.83 | 1.00 | 0.96 | 0.35 | 0.35 | 0.28 | 0.40 | 1.62 | 0.51 | 3.10 | 7.46 | 6.26 | 6.07 | 2.76 | 2.34 | 4.09 | 0.11 | 1.30 | 0.31 |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | -272.95 | -109.07 | -660.62 | -32.62 | 236.64 | 207.87 | 7.48 | 210.33 | 154.50 | -7.34 | 141.98 | 1.07 | -8.42 | 303.93 | 10.21 | 98.71 | 0.46 | 175.96 | 181.13 | |
Payments For Repurchase Of Common Stock | 243.35 | 106.05 | 648.38 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 9.02 | 4.47 | 55.13 | 28.93 | 37.14 | 37.10 | 21.62 | 27.38 | 17.05 | 12.53 | 4.32 | 9.22 | 24.34 | 13.99 | 7.74 | 15.15 | 5.75 | 1.32 | 1.58 | |
Arbutus Biopharma Corporation | NA | 1.34 | NA | NA | NA | 4.66 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Revenue From Contract With Customer Excluding Assessed Tax | 9.02 | 4.47 | 55.13 | 28.93 | 37.14 | 37.10 | 21.62 | 27.38 | 17.05 | 12.53 | 4.32 | 9.22 | 24.34 | 13.99 | 7.74 | 15.15 | 5.75 | 1.32 | 1.58 | |
Arbutus Biopharma Corporation | NA | 1.34 | NA | NA | NA | 4.66 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |